ArticlePharmacology research & perspectives2017

Exemestane potency is unchanged by common nonsynonymous polymorphisms in CYP19A1: results of a novel anti-aromatase activity assay examining exemestane and its derivatives.

Amity Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.